Dwight H. Egan
CIK: 0001712187
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Co-Diagnostics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- May 23, 2026CODX
Co-Diagnostics, Inc.
Award(A)Direct4.6K shares- - May 23, 2026CODX
Co-Diagnostics, Inc.
Disposition(D)Direct1.6K shares at avg. $5.07$8K - May 23, 2026CODX
Co-Diagnostics, Inc.
Exercise(M)DirectRestricted Stock Unit
4.6K shares- - Nov 23, 2025CODX
Co-Diagnostics, Inc.
Exercise(M)DirectRestricted Stock Unit
163.3K shares- - Nov 23, 2025CODX
Co-Diagnostics, Inc.
Award(A)Direct163.3K shares- - Nov 23, 2025CODX
Co-Diagnostics, Inc.
Disposition(D)Direct49.6K shares at avg. $0.35$17K - Aug 13, 2025CODX
Co-Diagnostics, Inc.
Award(A)DirectRestricted Stock Units
275K shares- - May 23, 2025CODX
Co-Diagnostics, Inc.
Exercise(M)DirectRestricted Stock Unit
163.3K shares- - May 23, 2025CODX
Co-Diagnostics, Inc.
Award(A)Direct163.3K shares- - May 23, 2025CODX
Co-Diagnostics, Inc.
Disposition(D)Direct51.7K shares at avg. $0.24$12K - Nov 23, 2024CODX
Co-Diagnostics, Inc.
Exercise(M)DirectRestricted Stock Unit
163.3K shares- - Nov 23, 2024CODX
Co-Diagnostics, Inc.
Disposition(D)Direct49.7K shares at avg. $1.01$50K - Nov 23, 2024CODX
Co-Diagnostics, Inc.
Award(A)Direct163.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 23, 2026 | CODX Co-Diagnostics, Inc. | Award(A) | 4,584 | - | $0 | Direct |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | Disposition(D) | 1,633 | $5.07 | $8,279 | Direct |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | Exercise(M) Restricted Stock Unit | 4,584 | - | - | Direct |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | Exercise(M) Restricted Stock Unit | 163,333 | - | - | Direct |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | Award(A) | 163,333 | - | - | Direct |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | Disposition(D) | 49,575 | $0.35 | $17,351 | Direct |
| Aug 13, 2025 | CODX Co-Diagnostics, Inc. | Award(A) Restricted Stock Units | 275,000 | - | - | Direct |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | Exercise(M) Restricted Stock Unit | 163,334 | - | - | Direct |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | Award(A) | 163,334 | - | - | Direct |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | Disposition(D) | 51,697 | $0.24 | $12,407 | Direct |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | Exercise(M) Restricted Stock Unit | 163,333 | - | - | Direct |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | Disposition(D) | 49,689 | $1.01 | $50,186 | Direct |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | Award(A) | 163,333 | - | $0 | Direct |
1-13 of 13 transactions
About Egan Dwight H
Egan Dwight H (SEC CIK 0001712187) files insider reports with the SEC as Chief Executive Officer of Co-Diagnostics, Inc. (CODX).
Signal8 holds 5 ownership filings by Egan Dwight H, all Form 4s, filed between Nov 25, 2024 and May 27, 2026. Those filings report 13 transactions, from Nov 23, 2024 to May 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Egan Dwight H's filings is in SALT LAKE CITY, UT.
Recent filings by Egan Dwight H
- May 23, 2026: Grant or award of CODX shares (Form 4, code A).
- May 23, 2026: Disposition to issuer transaction of CODX shares (Form 4, code D).
- May 23, 2026: Option exercise of CODX derivative securities (Form 4, code M).
- Nov 23, 2025: Option exercise of CODX derivative securities (Form 4, code M).
- Nov 23, 2025: Grant or award of CODX shares (Form 4, code A).
Other insiders filing for Co-Diagnostics, Inc. (CODX)
- Bohrer Daniel, EVP of Finance & Accounting
- Brown Brian Lee, Chief Financial Officer
- Abbott Richard David, President
- Murphy Edward L., Director
- SERBIN RICHARD S, Director
- Durenard Eugene, Director